Morphine-sparing effect by cox-1 inhibitor sustains analgesic function without compromising antigen-specific immunity and anti-tumor effect of naked DNA vaccine

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 1, 2010, Pages 91-104

  Sun, W Z ^a   Chang, M C ^a   Hsiao, P N ^a   Chen, C A ^a   Hsu, Y T ^a   Hsieh, C Y ^a   Cheng, W F ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Analgesia; Antigen specific immunity; Ketorolac; Morphine; T cell apoptosis

Indexed keywords

CALRETICULIN; CASPASE 3; CASPASE 7; CYCLOOXYGENASE 1 INHIBITOR; DNA VACCINE; GAMMA INTERFERON; KETOROLAC; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; REACTIVE OXYGEN METABOLITE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVATION; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNITY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR VOLUME;

EID: 77951738378     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300109     Document Type: Article

References (32)

1. Friedman JD, Dello Buono FA. Opioid antagonists in the treatment of opioid-induced constipation and pruritus. Ann Pharmacother 2001; 35:85-91. (Pubitemid 32216284)
2. Dudgeon DJ, Bruera E, Gagnon B, et al. A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients. J Pain Symptom Manage 2007; 33:365-71. (Pubitemid 46505075)
3. Barnett M. Alternative opioids to morphine in palliative care: a review of current practice and evidence. Postgrad Med J 2001; 77:371-378 (Pubitemid 32554281)
4. Cheng WF, Chen LK, Chen CA, et al. Chimeric DNA vaccine reverses morphine-induced immunosuppression and tumorigenesis. Mol Ther 2006; 13:203-210
5. Sacerdote P, Manfredi B, Mantegazza P, Panerai AE. Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Br J Pharmacol 1997; 121:834-840 (Pubitemid 27260792)
6. Eisenstein TK, Hilburger ME. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J Neuroimmunol 1998;83:36-44.
7. Wu WR, Zheng JW, Li N, Bai HQ, Zhang KR, Li Y Immunosuppressive effects of dihydroetorphine, a potent narcotic analgesic, in dihydroetorphine-dependent mice. Eur J Pharmacol 1999; 366:261-269 (Pubitemid 29080791)
8. O'Hara DA, Fanciullo G, Hubbard L, Maneatis T, Seuffert P, Bynum L, Shefrin A. Evaluation of the safety and efficacy of ketorolac versus morphine by patient-controlled analgesia for postoperative pain. Pharmacotherapy 1997; 17:891-899 (Pubitemid 27415094)
9. Henderson SO, Swadron S, Newton E. Comparison of intravenous ketorolac and meperidine in the treatment of biliary colic. J Emerg Med 2002; 23:237-241 (Pubitemid 35300243)
10. Larkin GL, Peacock WFt, Pearl SM, Blair GA, D'Amico F. Efficacy of ketorolac tromethamine versus meperidine in the ED treatment of acute renal colic. Am J Emerg Med 1999; 17:6-10. (Pubitemid 29045378)
11. Cheng WF, Hung CF, Chen CA, Lee CN, Su YN, Chai CY, Boyd DA, Hsieh CY, Wu TC. Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis. Vaccine 2005; 23:3864-3874
12. Cheng WF, Hung CF, Chai CY, Hsu KF, He L, Ling M, Wu TC. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest 2001; 108:669-678 (Pubitemid 32906195)
13. Lin K-Y, Guarnieri FG, Staveley-O'Carroll KF, Levitsky HI, August T, Pardoll DM, Wu T-C. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996; 56:21-26
14. Hsieh CY, Chen CA, Huang CY, Chang MC, Lee CN, Su YN, Cheng WF. IL-6-Encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways. Mol Ther 2007; 15:1890-1897
15. Bhargava HN, Thomas PT, Thorat S, House RV. Effects of morphine tolerance and abstinence on cellular immune function. Brain Res 1994; 642:1-10. (Pubitemid 24105683)
16. Cheng WF, Hung CF, Lee CN, Su YN, Chang MC, He L, Wu TC, Chen CA, Hsieh CY. Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways. Eur J Immunol 2004; 34:1892-900. (Pubitemid 39256071)
17. Hung CF, Cheng WF, Hsu KF, Chai CY, He L, Ling M, Wu TC. Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Res 2001; 61:3698-3703 (Pubitemid 32694982)
18. Rizzardini M, Mangolini A, Lupi M, Ubezio P, Bendotti C, Cantoni L. Low levels of ALS-linked Cu/Zn superoxide dismutase increase the production of reactive oxygen species and cause mitochondrial damage and death in motor neuron-like cells. J Neurol Sci 2005; 232:95-103. (Pubitemid 40585849)
19. Mattiasson G. Flow cytometric analysis of isolated liver mitochondria to detect changes relevant to cell death. Cytometry A 2004; 60:145-154 (Pubitemid 39079507)
20. Feltkamp MC, Smits HL, Vierboom MP, Minnaar RP, de Jongh BM, Drijfhout JW, ter Schegget J, Melief CJ, Kast WM. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol 1993; 23:2242-2249
21. Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Polo JM, Slater LA, Ling M, Wu TC. Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion. Hum Gene Ther 2002; 13:553-568 (Pubitemid 34253156)
22. Hung CF, Cheng WF, Chai CY, Hsu KF, He L, Ling M, Wu TC. Improving vaccine potency through intercellular spreading and enhanced MHC Class I presentation of antigen. J Immunol 2001; 166:5733-40. (Pubitemid 32374199)
23. Liao CW, Chen CA, Lee CN, Su YN, Chang MC, Syu MH, Hsieh CY, Cheng WF. Fusion protein vaccine by domains of bacterial exotoxin linked with a tumor antigen generates potent immunologic responses and antitumor effects. Cancer Res 2005; 65:9089-9098
24. Cheng WF, Hung CF, Lin KY, Ling M, Juang J, He L, Lin CT, Wu TC. CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination. Gene Ther 2003; 10:1311-1320
25. Zelcer S, Kolesnikov Y, Kovalyshyn I, Pasternak DA, Pasternak GW Selective potentiation of opioid analgesia by nonsteroidal anti-inflammatory drugs. Brain Res 2005; 1040:151-156 (Pubitemid 40467495)
26. Tarze A, Deniaud A, Le Bras M, et al. GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene 2007, 26:2606-2620 (Pubitemid 46632015)
27. Sacerdote P, Bianchi M, Gaspani L, Manfredi B, Maucione A, Terno G, Ammatuna M, Panerai AE. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 2000; 90:1411-1414 (Pubitemid 30351347)
28. Blais V, Zhang J, Rivest S. In altering the release of glucocorticoids, ketorolac exacerbates the effects of systemic immune stimuli on expression of proinflammatory genes in the brain. Endocrinol 2002; 143:4820-4827
29. Carretta A, Zannini P, Chiesa G, Altese R, Melloni G, Grossi A. Efficacy of ketorolac tromethamine and extrapleural intercostal nerve block on post-thoracotomy pain. A prospective, randomized study. Int Surg 1996; 81:224-228 (Pubitemid 27075791)
30. Banos JE, Barajas C, Martin ML, Hansen E, Cos MA, Bosch F, Martin R, Marco J, Dierssen T. A survey of postoperative pain treatment in children of 3-14 years. Eur J Pain 1999; 3:275-282 (Pubitemid 29446605)
31. Hunt R, Fazekas B, Thorne D, Brooksbank M. A comparison of subcutaneous morphine and fentanyl in hospice cancer patients. J Pain Symptom Manage 1999; 18:111-119 (Pubitemid 29409439)
32. Fragen RJ, Stulberg SD, Wixson R, Glisson S, Librojo E. Effect of ketorolac tromethamine on bleeding and on requirements for analgesia after total knee arthroplasty. J Bone Joint Surg Am 1995; 77:998-1002.